Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Osmotica Pharmaceuticals plc | 2,976,020 | reported | 08 Aug 2022 | tx 5+2,352,565 |
| Lantheus Holdings, Inc. | 232,420 | reported | 05 Mar 2025 | tx 51+418,904−209,709 |
| Organogenesis Holdings Inc. | 133,589 | reported | 10 Dec 2018 | tx 7+533,820−685,161 |
| IMMUNOMEDICS INC | 90,788 | reported | 20 Nov 2017 | tx 53+441,727−168,982 |
| Altimmune, Inc. | 12,241 | reported | 31 Dec 2014 | tx 5+92,241 |
| INVERNESS MEDICAL INNOVATIONS INC | 0 | reported | 03 Oct 2017 | tx 7+64,816−64,816 |
| KING PHARMACEUTICALS INC | 0 | reported | 31 Jan 2011 | tx 45+2,800,471−2,852,919 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2025 | GRANT_AWARD | Lantheus Holdings, Inc. | 70,909 | 0.00 USD | |
| 05 Mar 2025 | GRANT_AWARD | Lantheus Holdings, Inc. | 41,347 | 0.00 USD | deriv |
| 03 Mar 2025 | TAX_WITHHOLDING | Lantheus Holdings, Inc. | 8,637 | 94.86 USD | |
| 19 Dec 2024 | TAX_WITHHOLDING | Lantheus Holdings, Inc. | 15,446 | 91.15 USD | |
| 19 Dec 2024 | EXERCISE | Lantheus Holdings, Inc. | 16,102 | 12.42 USD | |
| 19 Dec 2024 | EXERCISE | Lantheus Holdings, Inc. | 16,666 | 6.00 USD | |
| 19 Dec 2024 | EXERCISE | Lantheus Holdings, Inc. | 16,666 | 0.00 USD | deriv |
| 19 Dec 2024 | EXERCISE | Lantheus Holdings, Inc. | 16,102 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Lantheus Holdings, Inc. | 131,496 | 0.00 USD | |
| 11 May 2023 | GRANT_AWARD | Lantheus Holdings, Inc. | 2,012 | 0.00 USD | |
| 11 May 2023 | GRANT_AWARD | Lantheus Holdings, Inc. | 3,798 | 0.00 USD | deriv |
| 27 Mar 2023 | SALE | Lantheus Holdings, Inc. | 13,290 | 81.13 USD | anomaly |
| 08 Sept 2022 | SALE | Lantheus Holdings, Inc. | 4,172 | 83.05 USD | anomaly |
| 08 Sept 2022 | SALE | Lantheus Holdings, Inc. | 23,852 | 84.10 USD | anomaly |
| 08 Sept 2022 | SALE | Lantheus Holdings, Inc. | 13,788 | 84.84 USD | anomaly |
| 08 Sept 2022 | EXERCISE | Lantheus Holdings, Inc. | 3,263 | 21.13 USD | |
| 08 Sept 2022 | EXERCISE | Lantheus Holdings, Inc. | 9,464 | 19.11 USD | |
| 08 Sept 2022 | EXERCISE | Lantheus Holdings, Inc. | 11,725 | 17.06 USD | |
| 08 Sept 2022 | EXERCISE | Lantheus Holdings, Inc. | 3,263 | 0.00 USD | deriv |
| 08 Sept 2022 | EXERCISE | Lantheus Holdings, Inc. | 9,464 | 0.00 USD | deriv |
| 08 Sept 2022 | EXERCISE | Lantheus Holdings, Inc. | 11,725 | 0.00 USD | deriv |
| 06 Sept 2022 | EXERCISE | Lantheus Holdings, Inc. | 1,693 | 19.78 USD | |
| 06 Sept 2022 | SALE | Lantheus Holdings, Inc. | 1,693 | 78.50 USD | |
| 06 Sept 2022 | EXERCISE | Lantheus Holdings, Inc. | 1,693 | 0.00 USD | deriv |
| 08 Aug 2022 | PURCHASE | Osmotica Pharmaceuticals plc | 850,000 | 1.55 USD | first after silence |
1 purchase reported after at least 12 months of silence — most recent on 08 Aug 2022.